Core Viewpoint - The company announced that its wholly-owned subsidiary, Xinjiang Guolin New Materials Co., Ltd., will suspend production for maintenance on the "25,000 tons/year high-quality crystal acetaldehyde project" starting from June 3, 2025, for approximately 60 days [1] Group 1 - The maintenance plan is expected to last around 60 days, with the specific resumption date dependent on the actual maintenance duration [1] - The company will fulfill its information disclosure obligations regarding the progress of this maintenance in accordance with relevant regulations [1] - Investors are advised to pay attention to investment risks associated with this production suspension [1]

关于子公司停产检修的公告 证券代码：300786 证券简称：国林科技 公告编号：2025-052 青岛国林科技集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或者重大遗漏。 2025年6月3日 特此公告。 青岛国林科技集团股份有限公司 董事会 根据化工企业生产工艺特点，为保障生产装置正常运行和安全稳定生产，青 岛国林科技集团股份有限公司（以下简称"公司"）的全资子公司新疆国林新材 料有限公司（以下简称"新疆国林"）拟按照检修计划对"2.5万吨/年高品质晶 体乙醛酸项目"生产线进行停产检修工作。 新疆国林拟于2025年6月3日起对"2.5万吨/年高品质晶体乙醛酸项目"生产 线进行停产检修，预计检修计划时间60天左右，具体复产时间以实际检修时间为 准。针对此次停产检修，公司已做好相关产品的供应预案，确保现有订单的安全 稳定供应，不会对公司经营情况造成较大影响。 公司将根据相关规定就本次停产检修进展情况及时履行信息披露义务，敬请 广大投资者注意投资风险。 ...

本实用新型专利"喷射装置"有助于提高臭氧在覆膜表面布气的均匀性，有 利于增强覆膜的粘性，促进覆膜的粘附效果，同时提高臭氧的利用率，保证产品 的良率。该项专利技术暂未应用到公司现有产品中。 证券代码：300786 证券简称：国林科技 公告编号：2025-053 关于取得专利证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或者重大遗漏。 青岛国林科技集团股份有限公司（以下简称"公司"）于近日收到国家知识 产权局颁发的实用新型专利证书，具体情况如下： | 专利名称 | 证书号 | 专利号 | 专利申请日期 | 专利类型 | | --- | --- | --- | --- | --- | | 臭氧发生器 | 第22911934号 | ZL 2024 2 1479662.7 | 2024年6月26日 | 实用新型 | | 喷射装置 | 第22906718号 | ZL 2024 2 1979555.0 | 2024年8月15日 | 实用新型 | 本实用新型专利"臭氧发生器"通过将接地电极板件、垫片和介质板件之间 围合形成螺旋形介质阻挡放电气隙，能够增加氧气电离的时间，有利于 ...

Core Viewpoint - The demand for glycolic acid in China is steadily increasing, projected to rise from 98,000 tons in 2022 to 108,000 tons in 2024, driven by its applications in pharmaceuticals, fragrances, and food additives, as well as emerging sectors like lithium battery electrolytes and biodegradable plastics [1][12]. Industry Overview - Glycolic acid is an organic compound with the formula C2H2O3, characterized by its white crystalline form and various industrial applications [2]. - The market for glycolic acid is expanding due to rising living standards and increased demand in various sectors [1][12]. Production Methods - The primary production methods for glycolic acid include oxalic acid electrolysis, glyoxal nitric oxidation, and ozone oxidation of anhydride, with domestic producers predominantly using glyoxal nitric oxidation [3][4]. Industry Chain - The glycolic acid industry chain involves upstream sectors like petrochemicals and biomass energy, providing essential raw materials, while downstream applications span pharmaceuticals, pesticides, dyes, and food additives [8]. Market Competition - The Chinese glycolic acid market is characterized by a dominance of large enterprises, with significant players including Hubei Hongyuan Pharmaceutical and Qingdao Guolin Technology, while smaller firms focus on niche markets [16][17]. Industry Development Trends - Innovations in production processes, such as using biomass-derived acetyl acid, are expected to enhance efficiency and product quality [21]. - Increased international cooperation is anticipated, particularly under the Belt and Road Initiative, which may expand market share and enhance technological capabilities [22]. - The pharmaceutical sector's growth is likely to broaden the consumption of glycolic acid, solidifying its market position as a crucial raw material for various drugs [24].

北京德和衡律师事务所 关于青岛国林科技集团股份有限公司 2024年年度股东大会的 法律意见书 德和衡证见意见(2025)第00095号 北京德和衡律师事务所 www.deheng.com.cn 中国北京市朝阳区建国门外大街 2 号银泰中心 C 座 11、12 层 Tel：010-85407666 邮编：100022 北京德和衡律师事务所 关于青岛国林科技集团股份有限公司 2024年年度股东大会的 法律意见书 德和衡证见意见(2025)第00095号 致：青岛国林科技集团股份有限公司 北京德和衡律师事务所（以下简称"本所"）接受青岛国林科技集团股份有限公司（以下 简称"公司"）的委托，指派本所律师出席贵公司 2024 年年度股东大会。本所律师依据《中 华人民共和国公司法》（以下简称"《公司法》"）、《上市公司股东会规则》（以下简称"《股 东会规则》"）、《青岛国林科技集团股份有限公司章程》（以下简称"《公司章程》"）及 相关法律法规，就本次股东大会的有关事宜出具本法律意见书。 本法律意见书仅就本次股东大会的召集和召开程序、会议召集人和出席会议人员的资格、 会议表决程序和表决结果的合法有效性等发表意见，并不对本次 ...

证券代码：300786 证券简称：国林科技 公告编号：2025-050 青岛国林科技集团股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 特别提示： 1、本次股东大会没有出现否决议案情形； 1、现场会议召开的时间：2025年5月15日（星期四）14:30。 2、网络投票时间：2025年5月15日，其中通过深圳证券交易所系统进行网络 投票的具体时间为2025年5月15日上午9:15-9:25，9:30-11:30，13:00-15:00；通过深 圳证券交易所互联网投票系统进行网络投票的具体时间为2025年5月15日 9:15-15:00期间的任意时间。 （二）股东大会召开的地点：山东省青岛市崂山区株洲路188号甲7楼会议室。 （三）会议召开方式：现场投票与网络投票相结合的方式。 （四）会议召集人：董事会。 （五）会议主持人：副董事长王承宝先生。 （六）本次股东大会的召集、召开、审议和表决程序符合《公司法》等法律、 法规及《公司章程》的有关规定，会议决议合法有效。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 ...

Group 1: Revenue and Business Performance - The company is currently experiencing stagnation in revenue growth, with the acetic acid production capacity unable to increase significantly. The core ozone equipment business is also declining year by year, and semiconductor equipment revenue has not yet ramped up [2][3] - The ozone business segment achieved revenue of 217 million CNY in 2024, showing a decline compared to 2019, but there are still 446 million CNY in unexecuted contracts, indicating stable operations [7] - The acetic acid project currently has a production capacity utilization rate of around 60%, with the inability to meet the initial target of 25,000 tons due to lower-than-expected downstream demand and market expansion challenges [14] Group 2: Future Strategies and Market Position - The company plans to stabilize its market share in the ozone business, gradually increase the production load and profitability of the acetic acid project, and seize the opportunity for domestic substitution in the semiconductor industry [2] - The company is actively exploring the domestic and international markets for acetic acid to improve capacity utilization and aims to enhance its performance to reward investors [3] - The company has established partnerships with leading enterprises in the cleaning equipment, photovoltaic, and panel sectors, indicating a strategic approach to collaboration in the semiconductor field [14] Group 3: Product Development and Technology - The company is developing products suitable for the 5nm advanced process in the semiconductor sector, with ongoing product validation and a focus on meeting customer needs [3][10] - The company produces a range of ozone-related products, including high-concentration ozone gas generators and ozone water systems, which are essential for semiconductor cleaning processes [12] - The company’s technology in semiconductor ozone equipment is on par with imported devices, and it aims to achieve domestic substitution through its extensive industry experience [12] Group 4: Stock Performance and Investor Relations - The company's stock price is influenced by various factors, and it is committed to enhancing its intrinsic value to provide good returns to shareholders [4] - As of May 9, 2025, the total number of shareholders is 20,568, reflecting the company's engagement with its investor base [14] - The company is not currently planning any mergers or acquisitions but will consider strategic opportunities in the semiconductor equipment sector as it aligns with its business goals [14]

Market Overview - The Shanghai Composite Index is at 3305.11 points, above the annual line, with an increase of 0.80% [1] - The total trading volume of A-shares is 646.819 billion yuan [1] Stocks Breaking Annual Line - A total of 233 A-shares have surpassed the annual line today [1] - Notable stocks with significant deviation rates include: - Jinkai Biological Science and Technology (10.11%) - Disen Power (9.84%) - Hanbo High-tech (8.84%) [1] Stock Performance Details - The top stocks with their respective performance metrics are as follows: - Jinkai Biological: Price increased by 10.32%, turnover rate 13.55%, latest price 33.02 yuan [1] - Disen Power: Price increased by 10.04%, turnover rate 1.77%, latest price 4.93 yuan [1] - Hanbo High-tech: Price increased by 9.42%, turnover rate 3.54%, latest price 15.33 yuan [1] - Other notable stocks include: - Jiashitang (9.97%, 3.57%, 13.13 yuan) - Sanmu Group (9.94%, 7.78%, 3.54 yuan) [1] Additional Stocks with Minor Deviations - Stocks with smaller deviation rates that have just crossed the annual line include: - Yongqing Environmental Protection - Dongjian Technology - Aishide [1]

证券代码：300786 证券简称：国林科技 公告编号：2025-049 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 青岛国林科技集团股份有限公司（以下简称"公司"）已于 2025 年 4 月 25 日在巨潮资讯网（http://www.cninfo.com.cn）披露了《2024 年年度报告》及《2024 年年度报告摘要》。 为进一步加强与投资者的互动交流，公司将参加由青岛证监局指导，青岛市 上市公司协会与深圳市全景网络有限公司联合举办的"2025 年青岛辖区上市公 司投资者网上集体接待日暨 2024 年度业绩说明会活动"，现将相关事项公告如 下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号（名称：全景财经），或下载全景路演 APP，参与本次互动交流。活动时间为 2025 年 5 月 12 日（星期一）15:00-17:00。 出席本次网上业绩说明会的人员有：董事长兼总经理丁香鹏先生，独立董事 赵永瑞先生，董事会秘书兼副总经理胡文佳女士，财务总监刘彦璐女士（如遇特 殊情况，参会 ...

Core Insights - The company reported a significant decline in net profit despite an increase in operating revenue, with net profit attributable to shareholders dropping by 71.46% and net profit excluding non-recurring gains and losses decreasing by 86.87% [1] Financial Performance Summary - Operating revenue for 2024 reached 493,037,354.27 yuan, a 23.33% increase from 399,770,522.35 yuan in 2023. The ozone equipment manufacturing segment generated revenue of 217,392,925.86 yuan, accounting for 44.09% of total revenue but decreased by 13.93%. In contrast, the chemical products manufacturing segment saw revenue of 203,391,883.87 yuan, representing 41.25% of total revenue and a substantial growth of 150.80% [2] - The net profit attributable to shareholders was -49,958,871.81 yuan, worsening from -29,137,344.28 yuan in the previous year. The net profit excluding non-recurring gains and losses was -54,835,102.70 yuan, compared to -29,344,122.29 yuan last year, indicating a more pronounced decline. The company attributed this drop to economic downturns, slower commissioning of ozone equipment, increased bad debt provisions, and rising expenses from early-stage R&D projects [3] - Basic earnings per share fell to -0.27 yuan, down 68.75% from -0.16 yuan per share in the previous year. The diluted earnings per share, excluding non-recurring gains and losses, also decreased significantly to -0.30 yuan [4] Expense Analysis - Overall expenses increased in 2024, with sales expenses rising by 13.82% to 40,012,843.77 yuan, management expenses increasing by 9.12% to 45,878,085.31 yuan, and financial expenses surging by 83.68% to 6,024,717.06 yuan. R&D expenses slightly decreased by 1.93% to 20,297,388.90 yuan [5] - The increase in sales expenses was driven by higher employee compensation and travel expenses, indicating greater investment in market expansion. Management expenses rose due to increased personnel and intermediary fees, reflecting higher operational costs. Financial expenses grew due to increased interest payments and reduced interest income [5] R&D and Innovation - R&D investment totaled 20,297,388.90 yuan, representing 4.12% of operating revenue. The number of R&D personnel increased from 88 to 104, with a higher proportion holding bachelor's degrees or above, indicating a focus on enhancing R&D talent [6] - Several R&D projects made progress, including the development of a 50kg/h IGBT ozone generator and a pilot experimental device for wastewater treatment, which, if successful, could enhance the company's technological competitiveness [7] Cash Flow Analysis - The net cash flow from operating activities significantly declined to -30,226,129.85 yuan, a 78.99% decrease from -16,887,066.58 yuan in the previous year, primarily due to increased inventory and accounts receivable [9] - Cash inflow from investing activities totaled 28,623,973.24 yuan, down 51.32%, while cash outflow was 55,227,598.78 yuan, a decrease of 58.67%. The net cash flow from investing activities was -26,603,625.54 yuan, an increase of 64.44% [10] - Cash inflow from financing activities reached 116,000,000.00 yuan, up 89.03%, due to new bank loans, while cash outflow was 128,166,675.91 yuan, an increase of 178.52%, driven by loan repayments and stock buybacks. The net cash flow from financing activities was -12,166,675.91 yuan, a decline of 179.27% [11]